The American Geriatrics Society released the 2019 updates to the Beers Criteria. What are the key takeaways for primary care physicians? Scroll through our slideshow to find out.
ADA Standards of Care for Overweight and Obesity to Debut at 2025 Scientific Sessions
The ADA unveils the association's first Standards of Care for Overweight and Obesity, with a chapter on weight stigma and bias one of the first released.
The Weekly Dose: Cannabis, Contraceptives, and Advances in Alzheimer Disease and Gonorrhea Treatment
Clinical insights on cannabis and dementia, hormonal contraceptives and postpartum depression, the FDA-approved blood test for Alzheimer disease, more.
Dual GLP-1/GLP-2 Agonist Dapiglutide Achieves 11.6% Mean Weight Loss at 28 Weeks in Phase 1b Trial
The investigational dual GLP-1/GLP-2 agonist led to 11.6% weight loss over 28 weeks with no lifestyle changes, showing strong safety and tolerability in the trial.
The Weekly Dose: Advancements in Colonoscopy, AI for Mammography, and Telemedicine Antibiotic Stewardship
Discover the latest breakthroughs in clinical research, from at-home cancer screening to AI advancements in mammography, shaping future healthcare practices.
Teledermatology-Dermoscopy Program Could Help Reduce Inequities in Skin Cancer Screening
A student-led teledermatology initiative that identified skin lesions in underserved communities could be a scalable model for early skin cancer detection and care.
Lenacapavir Approved for Twice-Yearly Injection for HIV Prevention, a Landmark FDA Decision
The only pre-exposure prophylaxis approved for twice-a-year dosing, lenacapavir "could be the transformative PrEP option we’ve been waiting for," one expert said.